Decheng Capital China Life Sciences USD Fund II, L.P.
SEC CIK 1650291 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BYSI | BeyondSpring Inc. | 10% | 1.56M | — | $344.2K | 3 | 2025-08-18 | 2025-10-16 |
Most active insiders at BYSI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Decheng Capital Global Healthcare GP, LLC | 10% | — | $283.9K |
| 2 | Decheng Capital China Life Sciences USD Fund II, L.P. | 10% | — | $227.7K |
| 3 | Decheng Capital Management III (Cayman), LLC | 10% | — | $39.0K |
| 4 | Cui Xiangmin | 10% | — | $13.8K |
| 5 | Huang Lan | CEO, Dir, 10% | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-10-20 | 2025-10-16+ | BYSI | BeyondSpring Inc. | Decheng Capital China Life Sciences USD Fund II, L.P. | 10% | S - Sale | $1.73 | -131.3K | 1.56M | -8% | -$227.7K |
| MI | 2025-08-28 | 2025-08-26+ | BYSI | BeyondSpring Inc. | Decheng Capital China Life Sciences USD Fund II, L.P. | 10% | S - Sale | $1.79 | -4,109 | 1.91M | -0.2% | -$7,358 |
| MI | 2025-08-20 | 2025-08-18+ | BYSI | BeyondSpring Inc. | Decheng Capital China Life Sciences USD Fund II, L.P. | 10% | S - Sale | $1.99 | -54.7K | 1.92M | -3% | -$109.2K |
Purchase Sale Sale after option exercise All abbreviations